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Albendazole and fenbendazole are imidazole derivatives that exhibit broad spectrum activity against 
parasites, but the low solubility of these drugs considerably reduces their effectiveness. Complexation of 
albendazole and fenbendazole with cyclodextrins (β-cyclodextrin and hydroxypropyl-β-cyclodextrin) in 
both water and an aqueous solution of polyvinylpyrrolidone (PVP-k30) was studied to determine if it could 
increase the solubility and dissolution rate of the drugs. In an aqueous solution, β-cyclodextrin increased 
the solubility of albendazole from 0.4188 to ∼93.47 µg mL-1 (223×), and of fenbendazole from 0.1054 to 
45.56 µg mL-1 (432×); hydroxypropyl-β-cyclodextrin, on the other hand, increased solubility to ∼443.06 
µg mL-1 (1058×) for albendazole and ∼159.36 μg mL-1 (1512×) for fenbendazole. The combination of 
hydroxypropyl-β-cyclodextrin and polyvinylpyrrolidone enabled a solubility increase of 1412× (∼591.22 
µg mL-1) for albendazole and 1373× (∼144.66 µg mL-1) for fenbendazole. The dissolution rate of the 
drugs was significantly increased in binary and ternary systems, with hydroxypropyl-β-cyclodextrin 
proving to be more effective. The presence of the water-soluble PVP-k30 increased the dissolution rate 
and amorphization of the complexes. Analysis of the changes in displacement and the profile of the 
cyclodextrin bands in the 1H NMR spectra revealed a molecular interaction and pointed to an effective 
complexation in the drug/cyclodextrin systems. Monomeric forms and nanoclusters of cyclodextrins 
were observed in the drug/cyclodextrin systems, suggesting that the increase in solubility of the drugs 
in the presence of cyclodextrins should not be attributed only to the formation of inclusion complexes, 
but also to the formation of cyclodextrin aggregates.
Keywords: Cyclodextrins/pharmacokinetics. Benzimidazoles/administration & dosage. Inclusion 
complexes. Cyclodextrin aggregates. Drug liberation/drug effects. Antiparasitic agents/analysis. 
Albendazole/analysis. Fenbendazole/analysis.
INTRODUCTION
B e n z i m i d a z o l e s  ( B N Z s )  a r e  a  c l a s s  o f 
chemotherapeutic agents with broad biological activity. 
They are employed as antiparasitic agents and antibacterial 
agents, and recently, important antitumor activity has 
been described (Duan, Liu, Rockwell, 2013). In addition, 
nitroaromatic derivates of benzimidazole are being studied 
for the treatment of tuberculosis and malaria (Camacho et 
al., 2011). Despite its wide-ranging biological activities, 
the low solubility of this class of substances has resulted 
in its inefficiency as a therapeutic agent, and parasitic and 
bacterial resistance against it has emerged.
Different strategies have been investigated to 
solve the limited aqueous solubility of benzimidazoles, 
including the use of surfactants, such as polysorbates 
and bile salts, or co-solvents (Daniel-Mwambete et al., 
2004; Miranda et al., 2011; Pradines et al., 2014). There 
is evidence that complexation with cyclodextrins (CDs) 
can increase the oral bioavailability of benzimidazoles 
(Evrard et al., 2002; Moriwaki et al., 2008; Pourgholami, 
Wangoo, Morris, 2008; Palomares-Alonso et al., 2010; 
Kumar et al., 2011a; Kumar et al., 2011b; Alamdarnejad 
et al., 2013; De Jaeghere et al., 2013; Pradines et al., 
2014; Ferreira et al., 2015). CDs are known for increasing 
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the solubility, dissolution efficiency, and bioavailability 
of different drugs through the formation of inclusion 
complexes. Recently, it has been observed that CDs are 
capable not only of forming inclusion complexes, but also 
of self-organizing to form nanoclusters that can contribute 
to the dissolution of low solubility drugs (Heydari, Kakhki, 
2013; Kurkov, Loftsson, 2013).
Stella and Rajewski (1997) have pointed out that 
the mechanism involved in the increase of BNZ solubility 
by the addition of CDs has advantages compared to that 
by the addition of co-solvents and surfactants. In the case 
of co-solvents and surfactants, the increase in solubility 
occurs through changes in the properties of the solution, 
and any change in the medium can compromise the 
solubilization of the drug. On the other hand, dissolution 
through the formation of inclusion complexes with CDs 
is not influenced by the medium.
The objective of this study was to develop and 
characterize the inclusion complexes of benzimidazole-
2-carbamates (albendazole and fenbendazole) and 
cyclodextrins, and to evaluate the effect of the cyclodextrins 
on the solubility of these drugs.
MATERIALS AND METHODS
Chemicals and reagents
Albendazole (ABZ),  fenbendazole (FBZ), 
polyvinylpyrrolidone (PVP-k-30, molecular weight 
360,000) and hydroxypropyl-β-cyclodextrin (HPβCD) 
were obtained from Sigma-Aldrich Co. (São Paulo, 
Brazil). β-Cyclodextrin (βCD, molecular weight 1135) 
was kindly provided by Labonathus Health Solutions (São 
Paulo, Brazil). Acetonitrile (HPLC grade) was obtained 
from J. T. Baker. Ultra-purified water was obtained 
through the Thermo Scientific reverse osmosis system. 
All other reagents were of analytical grade.
HPLC determination
The criteria used were based on the methodology 
described by Rodrigues, Reis, and Katiki (2016).
The BNZs (ABZ or FBZ) were quantified using 
an HPLC (Shimadzu Prominence Modular HPLC) with 
a diode-array detector set at a wavelength of 300 nm, 
a mobile phase of acetonitrile:0.04 M diammonium 
hydrogen phosphate (41:59 v/v) with pH 7.5-7.6, a flow 
rate of 1.5 mL min-1, an injection volume of 20 µL, and a 
reverse phase chromatographic column (Kromazil reverse 
RP C18, 100 A, 5 µm, 250 × 4.6 mm) equilibrated to 
ambient temperature and eluted under isocratic conditions. 
The mobile phase was previously degassed through 
vacuum filtration (KNF vacuum pump N810.FT.18, 100 
mbar) through a 45 µm Nylon membrane, followed by 
sonication in an ultrasonic bath (Altsonic 9L) for 15 min. 
Calibration curves were obtained using stock 
solutions of the drugs (ABZ or FBZ, 100 µg mL-1). Linear 
relationships were obtained in the range of 2 to 100 µg 
mL-1 for both drugs; the limit of detection (LOD) and 
limit of quantification (LOQ) values obtained for ABZ 
were 0.4855 and 1.6183 µg mL-1, respectively; and for 
FBZ they were 2.4575 and 8.1918 µg mL-1, respectively. 
The analytical performance parameters followed the 
recommendations of the guide for the validation of 
analytical methods (ICH, 2005).
Solubility studies
The phase solubility trials were performed according 
to the recommendations of Higuchi and Connors (1965). 
An excess of the drug (ABZ or FBZ) was added to 
dispersions containing increasing amounts of CDs (0 
to 40 mmol L-1) in the absence or presence of 0.1% 
PVP-k-30 as a co-complexing agent. The dispersions 
obtained were stirred (DragonLab MS-MS10 10-position 
magnetic stirrer) and kept at equilibrium for 72 h at room 
temperature. After the equilibrium time had passed, 
aliquots of the supernatant were filtered through a 0.45 µm 
cellulose acetate membrane filter, diluted with the mobile 
phase, transferred to a 1.5 mL amber vial, and the amount 
of drug dissolved was evaluated by liquid chromatography. 
The intrinsic solubility of the drugs (ABZ and FBZ) 
and the solubility of the binary and ternary complexes in 
purified water were determined using similar conditions.
Preparation of binary and ternary cyclodextrin 
complexes
The preparation of the binary (Drug/βCD or Drug/
HPβCD) and ternary (Drug/βCD-PVP 0.1% or Drug/
HPβCD-PVP 0.1%) complexes was performed by 
lyophilization: equimolar quantities of each drug, ABZ 
or FBZ, and CD, βCD, or HPβCD, were weighed and 
dispersed, separately, in purified water. The obtained 
dispersions were submitted to homogenization (DragonLab 
MS-MS10 magnetic stirrer) for 2 h, transferred to 
borosilicate lyophilization vials with a round bottom (φ, 
70 mm/300 mL), frozen at -78.5 °C with dry ice, protected 
from light by aluminum foil, and lyophilized (Liotop 
Lyophilizer L101) for 120 h. After freeze-drying, the 
complexes were crushed in a glass mortar and pulverized 
in a stainless-steel particle sieve with openings of 0.71 
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mm. For the ternary complex, equimolar quantities of 
drugs and CDs were separately dispersed in a 0.1% PVP 
solution (w/v). The dispersion results were subjected to 
the previously described conditions for solubility trials. 
Thermogravimetric Analysis (TG) and Differential 
Scanning Calorimetry (DSC)
DSC curves were obtained by a Shimadzu 
Differential Scanning Calorimetry DSC-60 system using 
a sample mass of 2.0 to 4.0 mg in a previously calibrated 
aluminum capsule with metallic indium (99.99% purity; 
Tfusion = 156.4 °C; ΔHfusion = 28.7 J g-1), under a dynamic 
nitrogen atmosphere (100 mL min-1) with a heating rate 
of 10 °C min-1 from 40 to 400 °C. 
Thermogravimetric curves (TG/DTG) were 
obtained by a Shimadzu differential thermogravimetry 
DTG-60 system using a sample mass of 4.0-6.0 mg in 
a previously calibrated aluminum capsule with calcium 
oxalate monohydrate (ASTM 1582-93) under a dynamic 
nitrogen atmosphere (100 mL min-1) with a heating rate of 
10 °C min-1 from 40 to 900 °C. The obtained curves were 
adjusted with the TA-60WS software.
Powder X-ray Diffraction (P-XRD)
The powder x-ray diffractograms were obtained 
with a Bruker diffractometer D8 Advance, using a Cu Kα 
radiation source at 40 KV and 40 mA, in the range of 5-60° 
(2θ), with a scan rate of 2° min-1, using polycrystalline 
silicon (Si) as the default.
Particle size and zeta potential measurements
The zeta potential and particle size/distribution 
measurements were performed on a Zetasizer Nano 
ZS/Malvern Instruments device. The scattering angle 
employed was 173°. The samples were diluted in milli-Q 
water at 25 °C in a 1:100 (w/v) ratio, submitted to an 
ultrasonic bath (Altsonic 9L) for 15 min, filtered through 
a 45 µm syringe filter, and taken for analysis. The results 
are reported as the mean of three measurements.
NMR spectroscopy
The 1H NMR spectra were obtained at 300 MHz 
(Bruker Avance, TXI SB 5 mm). The compounds were 
diluted to ∼10 mg mL-1 in DMSO-d6. The chemical shifts 
were recorded in ppm (δ) using tetramethylsilane (TMS) 
as an internal reference. 
In vitro release studies
Dissolution trials were performed on an Ethik 
Technology 299-6/TS dissolution device, using a rotating 
disc apparatus (Pharmacopeia, 2016), 900 mL of ultrapure 
water as a dissolution medium, a stirring speed of 100 rpm, 
and a temperature of 37 ± 0.5 °C.
For the preparation of the pills, amounts equivalent 
to 100 mg of the drug (ABZ or FBZ) and of the binary 
and ternary complexes were weighed and transferred to 
the matrices (rotating discs), and with the help of a 10-
ton hydraulic press (Flowscience Instruments & Trade, 
Brazil), they were compacted under a pressure of 250 
psi for 30 s. Subsequently, the matrices were coupled to 
the rotating disc apparatus and placed in the dissolution 
device. Aliquots of 10 mL were collected at time intervals 
of 5, 10, 15, 20, 30, 40, 50, 60, 90, 120, 180, and 240 min, 
and then placed back in the dissolution medium at the same 
temperature. The amount of dissolved drug was evaluated 
through liquid chromatography. The values obtained were 
corrected (Aronson, 1993). The accumulated amount of 
drug dissolved was plotted as a function of time.
RESULTS AND DISCUSSION
The main goal of adding CDs to pharmaceutical 
products is to increase the solubility of low-solubility 
drugs. The amount of CD needed to obtain the desired 
solubility is determined by the phase solubility diagram.
The phase solubility diagrams of the drugs ABZ and 
FBZ in the presence of βCD and HPβCD were of the type 
AL (Figure 1). The linear regression of the data generated 
angular coefficient values (S) of less than 1, assuming 
a stoichiometry of 1:1 (Table I) (Messner et al., 2010). 
The intrinsic solubility values (S0) obtained were lower 
than those observed for the intercept solubility (Sint), the 
latter being used to calculate the stability constant of the 
complexes (k1:1) (based on the equation of Higuchi and 
Connors, 1965):
k1:1 = Slope/Sint (1 – Slope)
where, k1:1 is the stability constant for 1st order diagrams, 
Sis the angular coefficient, and Sint the linear coefficient.
According to Pitha, Szente, and Greenberg (1983), 
only complexes with a stability constant kc between 
200 and 5000 M-1 seem to have practical applications, 
given that the unstable complexes (kc < 200 M-1) lead 
to premature release of the drug and the very stable 
complexes (kc > 5000 M-1) result in delayed or incomplete 
release of the drug in the body. For many complexes, 
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values of kc between 100 to 20,000 M-1 can be found 
(Challa et al., 2005).
The addition of water-soluble polymers to an 
aqueous solution of CD and drug is often linked to an 
increase in the stability constant of the complex (kc) and a 
reduction of the amount of CD required for incorporation 
of the drug (Loftsson, Másson, and Sigurjónsdóttir, 1999). 
The presence of polymers in drug/CD systems decreases 
the crystallinity of the drugs and has a synergistic effect 
on the solubilizing action of the CDs (Kurkov, Loftsson, 
2013).
The ternary complexes with ABZ had k1:1 values 
larger than those of the binary complexes, but this effect 
was not observed for the FBZ ternary complexes. Since 
the k1:1 values are strongly affected by the solubility values 
(Sint), distortions may be observed due to errors arising 
from the analytical method.
The solubility of the complexes increased compared 
to the pure drug (Table II). As expected, the modified 
cyclodextrin, hydroxypropyl-β-cyclodextrin, proved to 
be more effective in dissolving the drugs than the natural 
cyclodextrin, β-cyclodextrin.
The formation of inclusion complexes in solution 
does not necessarily guarantee attainment and isolation 
of the complexes in the solid state, since these are the 
result of a set of chemical equilibriums. The solid product 
may be a fine dispersion of the drug inside the CD or 
even a mixture consisting of inclusion complexes, non-
complexed drugs, self-organized CD aggregates, and even 
CDs in the hydrated form. 
Many techniques have been used to investigate 
the formation of inclusion complexes in the solid state, 
each having its own characteristics that not only allow 
detection of the formation of inclusion complexes, but 
also understanding of their chemical structure and the 
interactions that are established between the various 
components that make up the system.
Thermo-analytic techniques such as DSC and 
TG/DTG are widely used for the characterization of 
supramolecular complexes, such as inclusion complexes 
with CDs (Table III). The DSC curves of the physical 
mixtures for both drugs (ABZ or FBZ) had a thermal 
behavior that is representative of the sum of the substances. 
In the binary complexes, the event relating to the fusion of 
the drugs (ABZ and FBZ) was maintained, suggesting the 
presence of free drugs in the medium; the presence of the 
co-complexing agent PVP proved to be favorable to the 
amorphization of the drug/CD systems (Table III). 
The success of the interaction between the guest 
molecule and the CD can be qualitatively assessed by 
comparing the properties of the complexes and the CDs, 
FIGURE 1 - Phase solubility diagram of the drugs (ABZ and 
FBZ) in the presence of the CDs.
TABLE I - Parameters obtained from the linear regression of the curves of the phase solubility diagram
S0 Sint S R k1:1M–1
ABZ 1.5153E-6
ABZ/βCD 7.7710E-5 6.1735E-5 0.9987 794
ABZ/βCD-PVP 0.1% 5.9415E-5 6.8125E-5 0.9993 1146
ABZ/HPβCD 1.9162E-4 8.1486E-5 0.9967 425
ABZ/HPβCD-PVP 0.1% 1.8777E-4 9.0034E-5 0.9994 480
FBZ 3.5202E-7
FBZ/βCD 4.9647E-5 2.3359E-5 0.9955 471
FBZ/βCD-PVP 0.1% 6.9020E-5 1.5764E-5 0.9956 228
FBZ/HPβCD 4.5531E-5 7.0927E-5 0.9990 1558
FBZ/HPβCD-PVP 0.1% 3.9934E-5 5.3624E-5 0.9983 1343
*S0, intrinsic solubility; Sint, linear coefficient; S, slope; R, correlation coefficient and k1:1, stability constant
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or quantitatively assessed by evaluating the concentration 
of the substance in the inclusion complexes. An indirect 
method to evaluate the quantity of substance within the 
CDs is to compare the amount of water in the CD and in 
the complexes. In the formation of the complexes, the 
water molecules inside the cavity of the CD are replaced 
by the guest molecule. Through thermogravimetric 
analysis of the CDs and complexes between ambient 
temperature and a temperature below 100 °C, one can 
evaluate the release of water from the inside of the cavity 
of the CD and its replacement by the guest molecule 
(Moriwaki et al., 2008; Hădărugă, Hădărugă, Isengard, 
2012). In this case, the binary and ternary complexes 
showed a reduction of the water bonded to the inside 
of the cavity of the CDs, suggesting the replacement of 
water molecules and the interaction of the guest molecule 
with the CDs (Table III).
The diffractogram revealed intense reflections 
at 7, 11.2°, 13.8°, 17.9°, and 22° (2θ) for ABZ; and at 
6.6°, 11°, 13°, 25.9°, and 26.3° (2θ) for FBZ, which are 
TABLE II - Solubility values obtained for binary and ternary complexes
Complexes Solubility (µg mL
-1) SD IS
1 2 3 Average
ABZ 0.3865 0.4176 0.4522 0.4188 0.03 1
ABZ/βCD 87.7026 91.1609 101.5427 93.4687 7.20 223
ABZ/βCD-PVP 122.5868 128.7522 124.6638 125.3343 3.14 299
ABZ/HβCD 433.8756 457.9660 437.3408 443.0608 13.02 1058
ABZ/HPβCD-PVP 566.8074 596.6097 620.2490 591.2220 22.22 1412
FBZ 0.0811 0.1096 0.1255 0.1054 0.02 1
FBZ/βCD 41.1571 47.7081 47.8255 45.5636 3.82 432
FBZ/βCD-PVP 32.5536 40.4370 41.3538 38.1148 4.48 362
FBZ/HβCD 153.5421 165.5211 159.0208 159.3616 6.00 1512
FBZ/HPβCD-PVP 140.0309 152.3906 141.5664 144.6626 6.74 1373
*SD, standard deviation; IS, increase of solubility (expressed in number of times)
TABLE III - Thermal parameters obtained from the DSC and TG/DTG curves of the drugs (ABZ and FBZ) and binary and ternary 
complexes
DSC TG < 100°C TG
Tpeak (°C) ∆H (J g-1) ∆m (%) Tinitial (°C) ∆m (%)
βCD 13.726 29/166 14/84
HPβCD 5.596 28/144 6/94
ABZ 199/213 -78/-3 0.044 200/225/322/379/464 4/8/15/32/19*
ABZ/βCD 186-200 -42 10.110 29/150/257 10/3/72
ABZ/βCD-PVP 187-200 -39 9.827 30/155/259/393 10/3/58/16
ABZ/HPβCD 187-204 -28 4.508 32/145/255 5/2/85
ABZ/HPβCD-PVP 187-203 -25 5.182 31/131/239/405 6/2/70/16
FBZ 214/226 -105/-11 0.061 204/230/274/390/538 4/7/12/44/10*
FBZ/βCD 206-219 -65 8.900 26/165/273 11/3/70
FBZ/βCD-PVP 204-221 -57 9.590 28/132/261 10/3/72
FBZ/HPβCD 206-226 -34 5.124 29/137/260 5/2/83
FBZ/HPβCD-PVP 204-229 -38 5.260 30/125/254 5/2/87
*waste
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characteristics of the crystallinity of the compounds. 
βCD revealed intense reflections at 6.1°, 8.9°, 10.5°, 
12.4°, 12.6°, and 15.3° (2θ), which are characteristic 
of the crystallinity of the substance. HPβCD and PVP 
had amorphous behavior. The physical mixtures of the 
drugs (ABZ or FBZ) with both CDs (βCD or HPβCD) 
had reflections that were characteristic of each one of the 
isolated substances; the presence of PVP did not favor the 
amorphization of the mixtures. The binary and ternary 
complexes had a behavior similar to the physical mixtures, 
but with less intense reflections.
According to Pradines et al. (2014) the increase in 
the solubility of drugs in the presence of CDs cannot be 
attributed only to the formation of inclusion complexes, but 
also to the formation of self-organizing CD nanoclusters, 
which increase the solubility of the hydrophobic molecule 
through a micellar-type mechanism. The stability constant 
(kc) describes the result of all the effects of the CDs on the 
solubility of the drug. Not only inclusion complexes and non-
inclusion complexes are formed in the aqueous CD solution, 
but also bonds with the hydrogen molecules of neighboring 
CDs, forming self-organizing CD aggregates with an 
approximate diameter of 100 nm (Messner et al., 2010).
Table IV shows the mean hydrodynamic radius 
(RH), polydispersity index (PI), and zeta potential (Z) 
values of the drugs (ABZ and FBZ), the CDs (βCD 
and HPβCD), and the binary and ternary complexes. 
Although the modified CDs have functional groups on 
their surface that prevent self-clustering, self-organizing 
CD aggregates were observed in the binary and ternary 
systems for both CDs (Table IV). In the systems obtained 
with βCD, nanoclusters with a mean hydrodynamic 
radius of 188.6 ± 11.7 nm were identified; in the systems 
obtained with HPβCD, CD aggregates (180.9 ± 4.5 nm) 
and CD monomers (1.4 ± 0.3 nm) were observed. The 
results are in agreement with the literature (Coleman et 
al., 1992; González-Gaitano et al., 2002; Wu, Shen, He, 
2006; Glisoni et al., 2012).
Negative zeta potential (Z) values were obtained, 
indicating the stability of the complexes formed. The 
presence of the water-soluble polymer seems to favor 
steric repulsion, since the zeta potential (Z) values in 
ternary complexes were, in absolute value, larger than 
those of the corresponding binary complexes. All samples 
showed high polydispersity (PI > 0.08). 
Nuclear magnetic resonance spectroscopy (NMR) is 
one of the most commonly used techniques for analysis 
of the stability, stoichiometry, and geometry of inclusion 
complexes, because it allows study of the interactions 
between the guest molecule and the CD directly. 1H NMR 
studies can be used to monitor changes in the chemical 
shifts of protons as the composition of the complexes is 
TABLE IV - Mean values of hydrodynamic radius (RH, nm), polydispersity index (IP) and zeta potential (Z, mV) of drugs, CDs 
and binary and ternary complexes (n=6)
DH (nm) I (%) IP Z (mV)
βCD 188.6±11.7 100 0.627
HPβCD 180.9±4.5 
1.4±0.3
88.8 
11.2
0.457
ABZ 564.7±42.61 100 1.00 -32.5±5.14
ABZ/βCD 715.7±167.5 
167.8±29.82
82.4 
17.6
0.568 -27.1±4.80
ABZ/βCD-PVP 555.0±167.4 
137.2±27.94
85.9 
11.9
0.555 -33.8±5.29
ABZ/HPβCD 871.4±195.8 100 0.574 -23.7±3.74
ABZ/HPβCD-PVP 969.4±98.11 100 0.177 -24.1±4.55
FBZ 838.7±232.1 
237.2±56.44
79.8 
20.2
0.586 -34.6±4.41
FBZ/βCD 680.4±119.5 100 0.496 -27.8±4.70
FBZ/βCD-PVP 510.8±122.5 
140.6±23.88
84.5 
15.5
0.549 -29.7±4.87
FBZ/HPβCD 491.4±191.9 100 0.557 -31.2±4.42
FBZ/HPβCD-PVP 757.6±239.3 
218.0±53.83
77.3 
20.5
0.568 -33.5±4.91
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varied, and, as such, they provide information about the 
stoichiometry of the complexes and the dynamics of their 
formation. At the same time, when the drug is incorporated 
into the cavity of the CD, the hydrogen atoms located 
inside them (H-3 and H-5) undergo a significant chemical 
shift to higher value ranges, while the hydrogen atoms 
located on the outer surface of the CD (H-1, H-2, H-4, 
and H-6) are either not affected or undergo negligible 
shifts (Fernandes et al., 2003; Ikeda et al., 2004; Ferreira 
et al., 2015).
Figure 2 shows the 1H NMR spectra of the 
benzimidazoles, ABZ (A) or FBZ (B), recorded at 300 
MHz in DMSO-d6 with the signal assignments of the 
hydrogens. Figure 3 corresponds to the ABZ spectra in 
βCD binary (A) and ternary (B) systems. The spectrum 
recorded for ABZ in the presence of βCD (A) reveals 
the presence of signals corresponding to the drug and 
the cyclodextrin. The absence of protection, and the 
broadening of the signals in the range between 6 and 4 
ppm, corresponding to OH groups and CH2 groups of the 
pyran rings present in the βCD structure, suggest there are 
intermolecular interactions between the drug and βCD, 
but not effective complexation (Moriwaki et al., 2008; 
De Jaeghere et al., 2013). The addition of PVP (B) caused 
changes in the profile of the hydroxyl groups at 5.70 ppm 
(broad singlet), suggesting a better interaction between 
ABZ and βCD in the presence of PVP. 
The 1H NMR spectra of ABZ in the presence 
of HPβCD indicate the low solubility of the drug and 
the attempt to form inclusion complexes as shown in 
Figure  4 (A). The addition of the water-soluble polymer 
did not significantly alter the solubility of the system; 
no change in 1H NMR parameters was observed in 
Figure 4 (B). 
Figure 5 shows the 1H NMR spectra of FBZ in the 
binary systems with βCD (A) and HPβCD (B). The 1H 
NMR spectra of FBZ in the presence of both CDs revealed 
the presence of signals corresponding to the drug and the 
CDs, suggesting an interaction between the molecules. In 
the 1H NMR spectrum of FBZ in the presence of HPβCD 
(B), enlargement and distortion of the signals in the region 
between 6 and to 4 ppm is visible, corresponding to the 
OH groups and CH2 groups of the pyran rings present in 
the HPβCD structure, indicating effective complexing 
between FBZ and HPβCD. The spectra recorded after 
the addition of PVP to the binary systems FBZ/CD (βCD 
or HPβCD) did not reveal any alterations in the NMR 
spectrum.
The great importance of CDs in the development of 
medication containing low-solubility drugs lies in their 
ability to act as the carrier of hydrophilic drugs, thereby 
increasing the solubility and/or dissolution rate, and, 
consequently, the bioavailability of these drugs (Challa 
et al., 2005). The dissolution trials of the drugs and their 
complexes enabled the identification of differences in the 
dissolution rate of the binary and ternary complexes in 
FIGURE 2 - 1H-NMR spectra of ABZ (A) and FBZ (B) recorded in 300 MHz DMSO-d6.
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FIGURE 3 - 1H-NMR spectra of ABZ in the presence of βCD (A) and the water-soluble polymer (PVP) (B) recorded in 300MHz 
DMSO-d6.
FIGURE 4 - 1H-NMR spectrum of ABZ in the presence of HPβCD (A) and the water-soluble polymer (PVP) (B) recorded in 
300 MHz DMSO-d6.
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relation to the pure drugs. The dissolution rates of the pure 
drugs and of the binary and ternary complexes obtained 
with βCD were lower than that observed for HPβCD. 
In turn, the ternary complexes obtained with HPβCD 
had higher dissolution rates than the binary complexes 
(Figure 6). According to Kumar et al. (2011b) the increase 
in solubility and dissolution rate of FBZ in binary and 
ternary complexes obtained with β-cyclodextrin and 
PVP-k-30 can be attributed to the increase in the drug’s 
wetting properties.
CONCLUSION
Among the CDs compared in this study to increase 
the solubility of the benzimidazole-2-carbamates 
albendazole and fenbendazole, hydroxypropyl-β-
cyclodextrin showed the most potential. A synergistic 
effect between the water-soluble polymers PVP-k30 and 
HPβCD enabled a significant increase in the solubility and 
dissolution rate of the drugs. 
The analysis of the changes in displacement and the 
profile of the bands matching the cyclodextrins in the 1H 
NMR spectra revealed a molecular interaction and pointed 
to an effective complexation in the drug/CD systems. 
The increase in the solubility of the drugs, either by 
the formation of inclusion complexes or by the formation 
of self-organizing CD aggregates, constitutes a promising 
strategy for the pharmaceutical industry to increase the 
solubility of these drugs. However, in addition to low 
solubility, ABZ and FBZ have other problems, such as 
poor stability and intestinal permeability. Therefore, the 
biological evaluation of these drugs and their complexes 
will be pursued in our future studies.
FIGURE 5 - 1H-NMR spectra of FBZ in the presence of βCD (A) and HPβCD (B) recorded in 300 MHz DMSO-d6.
FIGURE 6 - Amount dissolved versus time obtained for the 
drugs (ABZ and FBZ) and their binary and ternary complexes.
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